Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de W. Staub
Age : 58
Public asset : 5,331,527 USD
Country of residence : Unknown
Linked companies :
No connection available

Biography of W. Staub 
Currently, W. Richard Staub is President-Research & Development Solutions at IQVIA Holdings, Inc. He is also on the board of TLC Operations, Inc. In his past career Mr. Staub occupied the position of Marketing Manager at Zeneca Pharmaceuticals, President, Chief Executive Officer & Director at Novella Clinical, Inc. and Senior Vice President-Global Business Development at Pharmaceutical Product Development LLC. W. Richard Staub received an undergraduate degree from The University of North Carolina at Charlotte.


Holdings of W. Staub 
Most Read News 
06/22ELON MUSK : Musk says Tesla's new car factories 'losing billions of dollars'
RE
06/28WARREN BUFFETT : Buffett's Berkshire buys more Occidental shares, raises stake to about 16.4%
RE
07/02ELON MUSK : Musk breaks silence on Twitter, posts a picture with the pope
RE
06/29MUKESH AMBANI : Factbox-Ambani children at centre of leadership change at India's Reliance
RE
06/23MARK MILLER : Column-Want to do something about your ailing retirement savings? Don't
RE
06/28RALPH HAMERS : UBS head of strategy to depart bank for entrepreneurship
RE
06/22TREVOR MILTON : Nikola founder Trevor Milton faces new fraud charge
RE
06/22RUPERT MURDOCH : Rupert Murdoch and Jerry Hall are getting a divorce - NYT
RE
06/21ELON MUSK : Musk says there are still a few unresolved matters with Twitter deal
RE
06/23MASAYOSHI SON : Nasdaq listing most likely for Arm - SoftBank's Son
RE
More news


© 2022 People and Ownership :   
W. Staub : Connections 
No connection available


Latest news about W. Staub 
2021TRANSCRIPT : IQVIA Holdings Inc. - Special Call
CI
2019TRANSCRIPT : IQVIA Holdings Inc. - Shareholder/Analyst Call
CI
2017TRANSCRIPT : Quintiles IMS Holdings, Inc. - Shareholder/Analyst Call
CI
More news